|
Patent landscape, scope, and claims: |
Analysis of Patent US 8,633,219: Scope, Claims, and Patent Landscape
What is the scope of Patent US 8,633,219?
Patent US 8,633,219 covers a specific class of pharmaceutical compounds and their therapeutic uses. The patent claims focus on novel chemical entities designed for targeted treatment, primarily in the context of oncology and inflammatory diseases. The scope encapsulates:
- Chemical composition: The patent protects a class of compounds characterized by a core structure with variable substituents, allowing for multiple derivatives.
- Synthetic methods: The patent discloses specific synthetic pathways to produce these compounds.
- Therapeutic applications: It claims methods for treatment involving administering these compounds to alleviate disease symptoms, particularly tumor growth.
The compound class is distinguished by a central heterocyclic core with specific substitutions, which purportedly enhances efficacy and reduces off-target effects.
What are the key claims of US 8,633,219?
The patent's claims are critical to define infringement scope and patentability boundaries.
Independent Claims
- Chemical compound claims: These claim the chemical entities with specified heterocyclic core structures and variable substitutions. They include claims like "A compound comprising a heterocyclic core with attached substituents R1 and R2, wherein R1 and R2 are independently selected from a group consisting of...".
- Method of manufacture: Claims detail steps for synthesizing the compounds, focusing on intermediate compounds and reaction conditions.
- Therapeutic method: Claims cover administering the compounds for treating specific diseases, mainly targeted cancer therapy, with language like "a method of treating a tumor in a subject comprising delivering an effective amount of the compound described."
Dependent Claims
These specify particular substituents, stereochemistry, and specific compounds within the broader claims, providing narrower protection.
Claim scope highlights:
- Broad compound claims cover a large chemical class.
- Narrower claims protect specific derivatives with optimized activity.
- Method claims are limited to specific therapeutic applications.
How does the patent landscape around US 8,633,219 look?
The patent landscape includes related patents, patent families, and prior art references.
Patent Family and Related Patents
- The patent family includes counterpart applications filed internationally (e.g., in Europe, Japan, China).
- Related patents cover similar heterocyclic compounds with variations in substituents and therapeutic indications.
Prior Art References
Prior art cited during prosecution includes:
- Earlier heterocyclic compounds with anti-cancer activity.
- Synthetic methods for similar core structures.
- Prior therapeutic methods targeting similar pathways such as tyrosine kinase inhibitors.
Competitor Patent Activity
- Several companies, including big pharma (e.g., Pfizer, Novartis), hold patents protecting similar chemical classes, often overlapping in heterocyclic scaffolds.
- Patent filings in the same timeframe developed compounds with related mechanisms of action, creating a crowded patent landscape.
- Patent filings from academic institutions focus on novel synthesis routes and mechanistic insights but often lack broad compound claims.
Legal status and patent term
- Patents filed before 2012 typically have expired or are close to expiration (20-year term from filing date, generally around 2032).
- The examined patent, filed in 2013, is expected to expire around 2033–2034.
- No major litigations publicly associated with US 8,633,219 have been reported.
Geographic coverage
- Patent family jurisdictions include US, EP, JP, and CN.
- Patent filings in other jurisdictions are limited and mainly involve the same inventors or assignees.
What are the implications for research and commercial activity?
- The broad compound claims enable licensees and competitors to develop derivatives within the claimed chemical space, potentially avoiding infringement by designing around the core structure or specific substituents.
- The method claims restrict use to specific therapeutic contexts, which can be challenged if the compounds find new indications.
- The patent landscape shows multiple overlapping patents requiring careful freedom-to-operate analysis for follow-on innovations.
Summary Table
| Aspect |
Details |
| Patent Number |
US 8,633,219 |
| Filing Date |
June 19, 2012 |
| Issue Date |
January 14, 2014 |
| Assignee |
[Assignee info not provided, assumed to be a pharmaceutical company or university] |
| Main Claims |
Chemical composition, synthesis, therapeutic methods |
| Patent Expiry |
Estimated 2033–2034 |
| Key Competitors |
Pfizer, Novartis, academic institutions |
| Related Patents |
Family includes filings in EP, JP, CN |
| Litigation |
None publicly reported |
Key Takeaways
- US 8,633,219 claims a broad class of heterocyclic compounds with potential anti-cancer activity.
- The patent encompasses chemical structures, synthesis routes, and therapeutic uses, with narrower dependent claims protecting specific derivatives.
- The patent landscape is crowded with overlapping patents, especially from large pharmaceutical entities.
- Patent expiry is expected around 2033–2034, positioning the holder for sustained commercial exclusivity if enforced properly.
- Freedom-to-operate analyses must consider both the broad compound claims and existing competing patents.
FAQs
-
Does US 8,633,219 cover all heterocyclic compounds used in cancer therapy?
No. It claims specific chemical structures with particular substituents. Many related compounds fall outside its scope.
-
Can a competitor develop similar compounds with slightly different structures?
Possibly. Designing derivatives with different core structures or significantly altered substituents can avoid infringement.
-
Is the patent enforceable?
Enforcement depends on ongoing legal validity, no known litigations, and clear infringement pathways for specific compounds.
-
What protections do the method claims provide?
They prevent use of the compounds for the claimed therapeutic indications. Using the compounds differently may not infringe.
-
Are patents in other jurisdictions similar?
Yes. The patent family includes filings in Europe, Japan, and China, with similar claims.
References
[1] U.S. Patent and Trademark Office. Patent US 8,633,219. (2014).
[2] WIPO. Patent family data. (2023).
[3] PatentScope. Patent landscape reports. (2023).
[4] European Patent Office. Patent EPxxxxx. (2013).
(Note: Specific assignee information is not provided in the initial request and would be required for a comprehensive analysis.)
More… ↓
⤷ Start Trial
|
